The research will help Mayo Clinic and Ultromics jointly develop an image analysis application to pinpoint the novel cardiac features of COVID-19 and help physicians more quickly triage and treat high-risk patients, according to a news release emailed to Becker’s Hospital Review.
The multi-site study will analyze echocardiography exams over a three-month period of 500 COVID-19 positive men and women, ages 18-89. Researchers are primarily interested in assessing automated cardiac measurements and ejection fraction, or the percentage of how much blood the heart’s left ventricle pumps with each contraction, to classify COVID-19 patient outcomes.
More articles on artificial intelligence:
AI can categorize lung nodules’ cancer risk, study suggests
Some physicians apprehensive about AI’s ability to diagnose COVID-19
AI spots potential COVID-19 treatment drug within two days
